Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group

Urology

Volumn 45, Issue 4, 1995, Pages 616-623

  Pilepich, Miljenko V ^{a,b,c,d,e,f,g,h,i,j,k,l}   Sause, William T ^{a,b,c,d,e,f,g,h,i,j,k,l}   Shipley, William U ^{a,b,c,d,e,f,g,h,i,j,k,l}   Krall, John M ^{a,b,c,d,e,f,g,h,i,j,k,l}   Lawton, Colleen A ^{a,b,c,d,e,f,g,h,i,j,k,l}   Grignon, David ^{a,b,c,d,e,f,g,h,i,j,k,l}   Al Sarraf, Muhyi ^{a,b,c,d,e,f,g,h,i,j,k,l}   Abrams, Ross A ^{a,b,c,d,e,f,g,h,i,j,k,l}   Caplan, Richard ^{a,b,c,d,e,f,g,h,i,j,k,l}   John, Madhu J ^{a,b,c,d,e,f,g,h,i,j,k,l}   Rotman, Marvin ^{a,b,c,d,e,f,g,h,i,j,k,l}   Cox, James D ^{a,b,c,d,e,f,g,h,i,j,k,l}   Doggett, R L Scotte ^{a,b,c,d,e,f,g,h,i,j,k,l}   Rubin, Philip ^{a,b,c,d,e,f,g,h,i,j,k,l}   Soloway, Mark S ^{b,c,d,e,f,g,h,i,j,k,l,m}  

^a Department of Radiation Oncology   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d Kaweah Delta Medical Center   (United States)

^e Radiation Oncology Center   (United States)

^f LDS HOSPITAL   (United States)

^g MEDICAL COLLEGE OF WISCONSIN   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

ⁱ SUNY DOWNSTATE MEDICAL CENTER   (United States)

^j UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

^l UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^m UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUTAMIDE; GOSERELIN;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HORMONE INHIBITION; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FLUTAMIDE; GOSERELIN; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS;

EID: 0028880521     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)80053-3     Document Type: Article

References (31)

1. Outcome for lymph node dissection negative T-1b, T-2 (A-2, B prostate cancer treated with external beam radiation therapy in RTOG 77-06
2. Patterns of care studies: dose-response observations for local control of adenocarcinoma of the prostate
3. Extended field (periaortic) irradiation in carcinoma of the prostate—analysis of RTOG 75-06
4. Prognostic factors in carcinoma of the prostate—analysis of RTOG study 75-06
5. Phase II Radiation Therapy Oncology Group study of hormonal cytoreduction with flutamide and Zoladex in locally advanced carcinoma of the prostate treated with definitive radiotherapy
6. Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen
7. Hormonal cytoreduction in locally advanced carcinoma of the prostate treated with definitive radiotherapy: preliminary results of RTOG 83-07
8. Prostate-specific antigen: an important marker for prostate cancer treated by external beam radiation therapy
9. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
10. Prostate-specific antigen as a predictor of radiotherapy response and pattern of failure in localized prostate cancer
11. Prostate specific antigen after external beam radiotherapy for prostatic cancer: followup
12. Is prostate specific antigen of clinical importance in evaluation outcome after radical prostatectomy?
13. The clinical evaluation of chemotherapeutic agents in cancer
14. The randomization and stratification of patients to clinical trials
15. Standards for breast-conservation treatment
16. Nonparametric Estimation from Incomplete Observations
17. A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
18. The significance of needle biopsy after irradiation for stage C adenocarcinoma of the prostate
19. The prognostic significance of postirradiation biopsy results in patients with prostatic carcinoma
20. Identification of residual cancer in prostate following radiation therapy: role of transrectal ultrasound guided biopsy and prostate specific antigen
21. Biopsy after external beam radiation therapy for adenocarcinoma of the prostate: correlation with original histological grade and current prostate specific antigen levels
22. Prostate specific antigen as a serum marker for adenocarcinoma of the prostate
23. The frequency and morbidity of local recurrence after definitive radiotherapy for stage T3 prostate cancer
24. 125I implantation
25. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatase in metastatic carcinoma of the prostate
26. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma
27. Medical Economics Data
28. Medical Economics Data
29. The effect of local tumor control on distant metastasis and survival in prostatic adenocarcinoma